Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII NASDAQ) stock market data APIs
$9.9835
0(0%)
as of February 6, 2026
Try our APIs with
free plan!
Drugs Made In America Acquisition II Corp. Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Prev. Close
9.9835
Open
9.9835
High
9.9835
Low
9.9835
52 wk Range
9.86-10.01
Market Cap
0
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Drugs Made In America Acquisition II Corp. Ordinary Shares data using free add-ons & libraries
Get Drugs Made In America Acquisition II Corp. Ordinary Shares Fundamental Data
Drugs Made In America Acquisition II Corp. Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Drugs Made In America Acquisition II Corp. Ordinary Shares Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Drugs Made In America Acquisition II Corp. Ordinary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Drugs Made In America Acquisition II Corp. Ordinary Shares News
New
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (the “Company”), a special purpose acquisition company formed as a Cayman Islands exempted comp...
Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ
[President Trump Signs Executive Order At The White House] Andrew Harnik/Getty Images News Family members of President Donald Trump and Commerce Secretary Howard Lutnick are set to profit as the U.S....
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of ...
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,...
Get Drugs Made In America Acquisition II Corp. Ordinary Shares fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
